Abstract
Topical imiquimod 5% cream has been used successfully to treat eyelid basal cell carcinoma, Bowen's disease of the eyelid and eyelid lentigo maligna. We report a case of borderline lentigo maligna on the eyelid that proved difficult to treat with surgery and, when the patient deferred surgery for personal reasons, imiquimod 5% cream was used with complete resolution of the lesion and no recurrence so far over a 3-year period of follow-up. The use of imiquimod in lentigo maligna and around the eye is discussed.
Key words::
Declaration of interest: The authors report no conflicts of interest and no funding sources.